TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/06/2025
Voltar para busca
Dado oficial do USPTO
SPARK PATH SPARK THERAPEUTICS · PIONEERING ACCESS TO HEALTHCARE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
70
Atualização mais recente
11/06/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
36, 45
Data de depósito
27/02/2018
Data de registro
30/04/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/04/2024
Última transação
11/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
09/03/2018
Primeiro uso no comércio
09/03/2018
Código do desenho
3
Tipo de titular
03
Localização do titular
Philadelphia, PA
Examinador
MORENO, PAUL
Unidade examinadora
L30
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the word "SPARK" and the word "PATH" with each letter of the word "PATH" appearing in a circle on one line with the wording "SPARK THERAPEUTICS PIONEERING ACCESS TO HEALTHCARE" appearing below. There is dot between the words "THERAPEUTICS" and "PIONEERING".
Titulares e representantes
Titulares
Spark Therapeutics, Inc.
Representantes
Edward Frederick Behm SAUL EWING LLP
Classificação técnica
Classes Nice
Classe 36Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 36
Providing information for patientsfamilies and health care providers about health care insurance coverageinsurance reimbursement programsinsurance payer policies and patient financial assistance programs
Classe 45
Health care case management advice and consultation servicescare coordination for patients and families and providing adviceinformation and assistance to patients and their families in dealing with medical service providershospitalsinsurance companiesothers involved in patient care
Publicações
Histórico de despachos e eventos da marca no USPTO.
70 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/06/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/06/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/04/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
30/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13/02/2024
PUBO
PUBLISHED FOR OPPOSITION
13/02/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/01/2024
EXPT
EXPARTE APPEAL TERMINATED
29/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/04/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/04/2023
GNRT
NON-FINAL ACTION E-MAILED
18/04/2023
CNRT
NON-FINAL ACTION WRITTEN
18/04/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
26/02/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
13/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/10/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
26/10/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/06/2022
GNSL
LETTER OF SUSPENSION E-MAILED
10/06/2022
CNSL
SUSPENSION LETTER WRITTEN
10/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/04/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
27/04/2022
EXPI
EX PARTE APPEAL-INSTITUTED
27/04/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
27/04/2022
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
27/04/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
27/10/2021
GNFR
FINAL REFUSAL E-MAILED
27/10/2021
CNFR
FINAL REFUSAL WRITTEN
27/10/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/09/2021
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
26/01/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
25/01/2021
GNSL
LETTER OF SUSPENSION E-MAILED
25/01/2021
CNSL
SUSPENSION LETTER WRITTEN
25/01/2021
IUAA
USE AMENDMENT ACCEPTED
25/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/01/2021
ALIE
ASSIGNED TO LIE
28/12/2020
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
23/12/2020
IUAF
USE AMENDMENT FILED
23/12/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/12/2020
EAAU
TEAS AMENDMENT OF USE RECEIVED
22/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/06/2020
GNRT
NON-FINAL ACTION E-MAILED
22/06/2020
CNRT
NON-FINAL ACTION WRITTEN
22/06/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
24/02/2020
ALIE
ASSIGNED TO LIE
31/01/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/07/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/07/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
16/07/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/01/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/01/2019
GNSL
LETTER OF SUSPENSION E-MAILED
05/01/2019
CNSL
SUSPENSION LETTER WRITTEN
05/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/12/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/12/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/12/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/06/2018
GNRT
NON-FINAL ACTION E-MAILED
13/06/2018
CNRT
NON-FINAL ACTION WRITTEN
13/06/2018
DOCK
ASSIGNED TO EXAMINER
12/06/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/03/2018
NWAP
NEW APPLICATION ENTERED
02/03/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SPARK PATH SPARK THERAPEUTICS · PIONEERING ACCESS TO HEALTHCARE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.